{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:25:45Z","timestamp":1791318345178,"version":"4.3.1"},"reference-count":259,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jns.2019.06.021","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T11:36:58Z","timestamp":1563363418000},"page":"137-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["SPS: Understanding the complexity"],"prefix":"10.1016","volume":"404","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3966-8027","authenticated-orcid":false,"given":"Rima","family":"El-Abassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Villemarette-Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"England","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.06.021_bb0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11940-009-0013-9","article-title":"Stiff person syndrome: advances in pathogenesis and therapeutic interventions","volume":"11","author":"Dalakas","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0015","first-page":"421","volume":"31","year":"1956","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jns.2019.06.021_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2011.05.005","article-title":"Stiff-person syndrome (SPS)and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies","volume":"37","author":"Ali","year":"2011","journal-title":"JAutoimmun"},{"issue":"5","key":"10.1016\/j.jns.2019.06.021_bb0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"Clinical significance of glutamic acid decarboxylaseantibodies in patients with epilepsy","volume":"51","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2019.06.021_bb0030","first-page":"583","article-title":"Stiff-man syndrome and type I diabetes mellitus: a common autoimmunepathogenesis?","volume":"24","author":"Solimena","year":"1988","journal-title":"Ann. Ist. Super. Sanita"},{"key":"10.1016\/j.jns.2019.06.021_bb0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.65.5.633","article-title":"Review of 23 patients affected by the stiff man syndrome:clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressiveencephalomyelitis with rigidity","volume":"65","author":"Barker","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course,treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0045","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/jnnp.43.12.1125","article-title":"A patient with reflex myoclonus and muscle rigidity:\u201cjerking stiff-man syndrome\u201d","volume":"43","author":"Leigh","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0050","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/jnnp.45.12.1159","article-title":"Jerking stiff-man syndrome","volume":"45","author":"Alberca","year":"1982","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0055","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/jnnp.2010.229104","article-title":"Antiglycine-receptor encephalomyelitis with rigidity","volume":"82","author":"Mas","year":"2011","journal-title":"J. Neurol. Neurosug. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF00936885","article-title":"Stiff man syndrome: neurophysiological findings in eightpatients","volume":"242","author":"Meinck","year":"1995","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF00936885","article-title":"Stiff man syndrome: neurophysiological findings in eightpatients","volume":"242","author":"Meinck","year":"1995","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0070","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/01.wnl.0000183068.42803.33","article-title":"Eye movement abnormalities in stiff person syndrome","volume":"65","author":"Economides","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/01.wnl.0000319725.22925.b4","article-title":"Stiff eyes in stiff-person syndrome","volume":"71","author":"Oskarsson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5334\/tohm.316","article-title":"Clinical spectrum of stiff personsyndrome: a review of recent reports","volume":"6","author":"Sarva","year":"2016","journal-title":"Tremor. Other. Hyperkinet Mov. (N Y)."},{"key":"10.1016\/j.jns.2019.06.021_bb0085","first-page":"906","article-title":"Head retraction reflex in stiff-man syndrome and related disorders","volume":"18","author":"Berger","year":"2003","journal-title":"MovDisord"},{"key":"10.1016\/j.jns.2019.06.021_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00315688","article-title":"Sudden death and paroxysmal autonomicdysfunction in stiff-man syndrome","volume":"238","author":"Mitsumoto","year":"1991","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2019.06.021_bb0095","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.65.5.633","article-title":"Review of 23 patients affected by the stiffman syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressiveencephalomyelitis with rigidity","volume":"65","author":"Barker","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/mds.870060104","article-title":"Stiff-person syndrome: an autoimmune disease","volume":"6","author":"Blum","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.06.021_bb0105","first-page":"479","article-title":"Electrophysiological findings in a case of stiffman syndrome associated with epilepsy and nocturnal myoclonus","volume":"48","author":"Martinelli","year":"1978","journal-title":"Riv. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp.47.3.280","article-title":"The stiff-man syndrome: new pathophysiological aspects fromabnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine","volume":"47","author":"Meinck","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v58n1007","article-title":"Psychiatric consultations in stiff-man syndrome","volume":"58","author":"Tinsley","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0120","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","article-title":"The clinical spectrum of anti-GAD antibody-positive patientswith stiff-person syndrome","volume":"55","author":"Dalakas","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1537-2995.1999.39399219285.x","article-title":"Frequency of immediate adverse effectsassociated with therapeutic apheresis","volume":"39","author":"McLeod","year":"1999","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.jns.2019.06.021_bb0130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/jnnp.74.4.462","article-title":"Specific phobia is a frequent non-motor feature in stiff mansyndrome","volume":"74","author":"Henningsen","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0896-6273(91)90077-D","article-title":"Two genes encode distinct glutamatedecarboxylases","volume":"7","author":"Erlander","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2019.06.021_bb0140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.65.5.633","article-title":"Review of 23 patients affected by the stiffman syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressiveencephalomyelitis with rigidity","volume":"65","author":"Barker","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0145","article-title":"Stiff-person syndrome: insights into a complex autoimmunedisorder","author":"Baizabal-Carvallo","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2019.06.021_bb0150","first-page":"207","article-title":"From stiff man syndrome to stiff person spectrum disorders","volume":"89","author":"Nervenarzt","year":"2018"},{"issue":"16","key":"10.1016\/j.jns.2019.06.021_bb0155","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, andmyoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology."},{"issue":"12","key":"10.1016\/j.jns.2019.06.021_bb0160","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/jnnp.2010.229104","article-title":"Antiglycine-receptor encephalomyelitis with rigidity","volume":"82","author":"Mas","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidylpeptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann. Neurol."},{"issue":"17","key":"10.1016\/j.jns.2019.06.021_bb0170","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: anew variant with DPPX antibodies","volume":"82","author":"Balint","year":"2014","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, statusepilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, andanalysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol."},{"issue":"22","key":"10.1016\/j.jns.2019.06.021_bb0180","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199005313222202","article-title":"Autoantibodies to GABA-ergic neurons andpancreatic \u03b2 cells in stiff-man syndrome","volume":"322","author":"Solimena","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jns.2019.06.021_bb0185","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0166-2236(91)90044-U","article-title":"Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-mansyndrome and insulin-dependent diabetes mellitus","volume":"14","author":"Solimena","year":"1991","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jns.2019.06.021_bb0190","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamicacid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jns.2019.06.021_bb0195","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2169\/internalmedicine.40.968","article-title":"Stiff-person syndromeassociated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer","volume":"40","author":"Kono","year":"2001","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb0200","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1212\/01.wnl.0000237558.83349.d0","article-title":"Stiff person syndrome with cerebellar disease and high-titer anti-GADantibodies","volume":"67","author":"Rakocevic","year":"2006","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.jns.2019.06.021_bb0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(96)00065-2","article-title":"Anti-gabaergic neuronautoantibodies in a patient with stiff-man syndrome and ataxia","volume":"143","author":"Giometto","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.06.021_bb0210","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1212\/01.wnl.0000237558.83349.d0","article-title":"Stiff person syndrome with cerebellar disease and high-titer anti-GADantibodies","volume":"67","author":"Rakocevic","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2019.06.021_bb0215","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1212\/01.wnl.0000237558.83349.d0","article-title":"Stiff person syndrome with cerebellar diseaseand high-titer anti-GAD antibodies","volume":"67","author":"Rakocevic","year":"2006","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patientswith therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.jns.2019.06.021_bb0235","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","article-title":"The clinical spectrum of anti-GAD antibody-positivepatients with stiff-person syndrome","volume":"55","author":"Dalakas","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2019.06.021_bb0240","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/jnnp.41.5.458","article-title":"Stiff-man syndrome associated withnocturnal myoclonus and epilepsy","volume":"41","author":"Martinelli","year":"1978","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"16","key":"10.1016\/j.jns.2019.06.021_bb0245","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in apatient with stiff-man syndrome, epilepsy, and type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"7\u20138","key":"10.1016\/j.jns.2019.06.021_bb0250","first-page":"269","article-title":"Anti glutamate-decarboxylase antibodies: a liaison between localisation relatedepilepsy, stiff-person syndrome and type-1 diabetes mellitus","volume":"67","author":"Sz\u0171cs","year":"2014","journal-title":"Ideggyogy Sz."},{"issue":"5","key":"10.1016\/j.jns.2019.06.021_bb0255","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"Clinical significance of glutamic acid decarboxylaseantibodies in patients with epilepsy","volume":"51","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.jns.2019.06.021_bb0260","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic aciddecarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2019.06.021_bb0265","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2169\/internalmedicine.44.1174","article-title":"Type 1 diabetes mellitus and drug-resistant epilepsy:presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinalfluid","volume":"44","author":"Yoshimoto","year":"2005","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patientswith therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2019.06.021_bb0275","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.19.4.268","volume":"19","author":"Campbell and Hugh SUBACUTE MYOCLONIC SPINAL NEURONITIS","year":"1956","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.jns.2019.06.021_bb0280","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.10279","article-title":"Stiff man syndrome and related conditions","volume":"17","author":"Meinck","year":"2002","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2019.06.021_bb0285","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mus.20653","article-title":"Rigidity and spasms from autoimmune encephalomyelopathies:Stiff-Person syndrome","volume":"34","author":"Espay","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2019.06.021_bb0290","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000339446","article-title":"Childhood stiff-person syndrome improved with rituximab","volume":"4","author":"Fekete","year":"2012","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0295","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes:characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain."},{"key":"10.1016\/j.jns.2019.06.021_bb0300","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.19.4.268","article-title":"Subacute myoclonic spinal neuronitis","volume":"19","author":"Campbell","year":"1956","journal-title":"J. Neurol. Neurosug. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0305","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1212\/NXI.0000000000000438","article-title":"Glycine receptor modulating antibody predicting treatable stiff-personspectrum disorders","volume":"5","author":"Hinson","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2019.06.021_bb0310","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/99.1.27","article-title":"Progressive encephalomyelitis with rigidity","volume":"99","author":"Whiteley","year":"1976","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.06.021_bb0315","article-title":"Progressiveencephalomyelitis with rigidity and myoclonus","author":"Turner","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000212375","article-title":"Stiff person syndrome","volume":"29","author":"Duddy","year":"2009","journal-title":"Front Neurol. Neurosci."},{"key":"10.1016\/j.jns.2019.06.021_bb0325","first-page":"2268","article-title":"A case of glycine-receptor antibody-associatedencephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings","volume":"258","author":"Piotrowicz","year":"2011","journal-title":"JNeurol"},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0330","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/WCO.0000000000000450","article-title":"Redefining progressive encephalomyelitis with rigidity andmyoclonus after the discovery of antibodies to glycine receptors","volume":"30","author":"Crisp","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0335","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1073\/pnas.93.10.4529","article-title":"Onconeural antigens and paraneoplastic neurologic disorders: at the intersection ofcancer, immunity, and the brain","volume":"93","author":"Darnell","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2019.06.021_bb0340","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb0345","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/mds.870120512","article-title":"Chorea in fifty consecutive patients withrheumatic fever","volume":"12","author":"Cardoso","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.06.021_bb0350","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","article-title":"Stiff-person syndrome with amphiphysin antibodies: distinctivefeatures of a rare disease","volume":"71","author":"Murinson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb0355","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ana.20529","article-title":"Amphiphysin autoimmunity: paraneoplasticaccompaniments","volume":"58","author":"Pittock","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0360","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0365","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00415-010-5501-z","article-title":"An uncommon paraneoplastic Ri-positive opsoclonus-myoclonus-likesyndrome and stiff-person syndrome with elevated glutamate\/GABA ratio in the cerebrospinal fluidafter breast cancer","volume":"257","author":"Th\u00fcmen","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0370","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-mansyndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0375","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/art.1780370621","article-title":"Treatment of stiff-mansyndrome with intravenous immune globulin","volume":"37","author":"Karlson","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2019.06.021_bb0380","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarbo.xylase in apatient with stiff-man syndrome, epilepsy, and type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb0385","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course,treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0390","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jnr.490280213","article-title":"T-lymphocyte entry into the central nervous system","volume":"28","author":"Hickey","year":"1991","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2019.06.021_bb0395","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2008.10.002","article-title":"Cerebrospinal fluid T cell responses against glutamic aciddecarboxylase 65 in patients with stiff person syndrome","volume":"32","author":"Skorstad","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jns.2019.06.021_bb0400","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-physiol-021909-135843","article-title":"Integrated brain circuits: astrocytic networks modulate neuronalactivity and behavior","volume":"72","author":"Haydon","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jns.2019.06.021_bb0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of auto-antibodies against brain antigens in healthand disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0410","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2014-000076","article-title":"Presence of anti-GAD in a non-diabetic populationof adults; time dynamics and clinical influence: results from the HUNT study","volume":"3","author":"S\u00f8rgjerd","year":"2015","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.jns.2019.06.021_bb0415","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/imt-2017-0146","article-title":"Immunologic treatment of Parkinson's disease","volume":"10","author":"Jankovic","year":"2018","journal-title":"Immunotherapy."},{"key":"10.1016\/j.jns.2019.06.021_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.02.007","article-title":"Movement disorders in multiple sclerosis and other demyelinatingdiseases","volume":"328","author":"Mehanna","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.06.021_bb0425","doi-asserted-by":"crossref","first-page":"780e4","DOI":"10.1212\/WNL.57.5.780","article-title":"Stiff person syndrome: quantification, specificity, andintrathecal synthesis of GAD65 antibodies","volume":"57","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb0430","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jneuroim.2010.07.019","article-title":"Qualitative andquantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis inpatients with stiff person syndrome","volume":"229","author":"Jarius","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.jns.2019.06.021_bb0435","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jamaneurol.2013.3499","article-title":"Neuronal surface and glutamic acidecarboxylase autoantibodies in nonparaneoplastic stiff person syndrome","volume":"70","author":"Chang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0440","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archneur.61.6.902","article-title":"Anti-glutamic acid decarboxylase antibodies in the serum andcerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity","volume":"61","author":"Rakocevic","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0445","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.4049\/jimmunol.175.11.7755","article-title":"Analysis of GAD65 autoantibodies in stiff-person syndromepatients","volume":"175","author":"Raju","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb0450","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jneuroim.2010.07.019","article-title":"Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specificintrathecal antibody synthesis in patients with stiff person syndrome","volume":"229","author":"Jarius","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"15 Supplement","key":"10.1016\/j.jns.2019.06.021_bb0455","article-title":"Serial CSF Studies of Anti-GAD Antibodies and GAD-IgG Intrathecal Synthesis in Stiff-Person Syndrome (SPS): Correlation withDisease Severity and Progression (P6.036)","volume":"90","author":"Alexopoulos","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2019.06.021_bb0460","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylaseantibodies: study of 14 patients","volume":"58","author":"Honnorat","year":"2001","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2019.06.021_bb0465","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1212\/WNL.49.4.1026","article-title":"Autoantibodies to glutamic acid decarboxylase in three patientswith cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity","volume":"49","author":"Saiz","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb0470","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/brain\/awl245","article-title":"Autoimmunity to GABAA-receptor-associated protein in stiff person syndrome","volume":"129","author":"Raju","year":"2006","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0475","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterization of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0480","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJM199302253280805","article-title":"Autoantibodies to a 128-kd synaptic protein in three womenwith the stiff-man syndrome and breast cancer","volume":"328","author":"Folli","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb0485","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1084\/jem.178.6.2219","article-title":"The synaptic vesicle-associated protein amphiphysin isthe 128-kD autoantigen of Stiff-man syndrome with breast cancer","volume":"178","author":"De Camilli","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb0490","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0896-6273(00)81165-4","article-title":"Autoimmunity to gephyrin in stiff-man syndrome","volume":"26","author":"Butler","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2019.06.021_bb0495","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","article-title":"Glycine receptor autoimmune spectrumwith stiff-man syndrome phenotype","volume":"70","author":"McKeon","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0500","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1212\/01.wnl.0000436617.40779.65","article-title":"Glycine receptor antibodies in stiff-person syndrome andother GAD-positive CNS disorders","volume":"81","author":"Alexopoulos","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2019.06.021_bb0505","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","article-title":"Clinical and immunologic investigations in patients with stiff-person spectrum disorder","volume":"73","author":"Martinez-Hernandez","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0510","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and relatedsyndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonzalez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.06.021_bb0515","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2014.3602","article-title":"Antibodies to aquaporin 4, myelinoligodendrocyteglycoprotein, and the glycine receptor alpha1 subunit in patients with isolated opticneuritis","volume":"72","author":"Martinez-Hernandez","year":"2015","journal-title":"JAMA Neurol."},{"issue":"20","key":"10.1016\/j.jns.2019.06.021_bb0520","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassiumchannel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.jns.2019.06.021_bb0525","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/WNL.0000000000001183","article-title":"Neuropathologic features of antidipeptidyl-peptidase-like protein-6 antibody encephalitis","volume":"84","author":"Stokin","year":"2015","journal-title":"Neurology."},{"issue":"17","key":"10.1016\/j.jns.2019.06.021_bb0530","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","article-title":"Progressiveencephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies","volume":"82","author":"Balint","year":"2014","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb0535","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis andantibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0540","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1212\/NXI.0000000000000086","article-title":"Prednisolone andazathioprine are effective in DPPX antibody-positive autoimmune encephalitis","volume":"2","author":"Stoeck","year":"2015","journal-title":"Neurol. (R) Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0545","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0896-6273(02)01185-6","article-title":"The CD26-relateddipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels","volume":"37","author":"Nadal","year":"2003","journal-title":"Neuron."},{"issue":"10","key":"10.1016\/j.jns.2019.06.021_bb0550","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","article-title":"Anti-DPPX encephalitis:pathogenic effects of antibodies on gut and brain neurons","volume":"85","author":"Piepgras","year":"2015","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb0555","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yjmcc.2009.07.013","article-title":"Molecular determinants of cardiac transient outward potassium current(I(to)) expression and regulation","volume":"48","author":"Niwa","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.jns.2019.06.021_bb0560","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.neuron.2011.08.008","article-title":"DPP6 establishes the A-type K(+)current gradient critical for the regulation of dendritic excitability in CA1 hippocampal neurons","volume":"71","author":"Sun","year":"2011","journal-title":"Neuron."},{"issue":"29","key":"10.1016\/j.jns.2019.06.021_bb0565","doi-asserted-by":"crossref","first-page":"21458","DOI":"10.1074\/jbc.M112.444372","article-title":"Altered cortical GABAA receptorcomposition, physiology, and endocytosis in a mouse model of a human genetic absence epilepsysyndrome","volume":"288","author":"Zhou","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.jns.2019.06.021_bb0570","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1093\/hmg\/ddl174","article-title":"A GABRB3 promoter haplotype associated withchildhood absence epilepsy impairs transcriptional activity","volume":"15","author":"Urak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2019.06.021_bb0595","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.51.1.85","article-title":"Physiologic studies of spinal inhibitorycircuits in patients with stiff-person syndrome","volume":"51","author":"Floeter","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb0600","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-131-7-199910050-00008","article-title":"The stiff-person syndrome: an autoimmune disorder affectingneurotransmission of gamma-aminobutyric acid","volume":"131","author":"Levy","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb0605","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM200104193441612","article-title":"Anxiety at the frontier of molecular medicine","volume":"344","author":"Weinberger","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb0610","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.WNL.0000092016.98256.21","article-title":"Clinically disparate stiff-person syndrome with GAD65autoantibody in a father and daughter","volume":"61","author":"Burns","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb0615","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.clinph.2015.03.010","article-title":"Familial case reports of stiff-person syndrome","volume":"126","author":"Xiao","year":"2015","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2019.06.021_bb0620","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000369784","article-title":"GAD antibody-associated late-onset cerebellarataxia in two female siblings","volume":"6","author":"Kuchling","year":"2014","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0625","first-page":"1550","article-title":"Eisenbarth GS:association of HLA-DQB1*0201 with stiff-man syndrome","volume":"77","author":"Pugliese","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jns.2019.06.021_bb0630","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0635","first-page":"421","article-title":"Progressive fluctuating muscular rigidity and spasm (\u2018stiff-man'syndrome); report of a case and some observations in 13 other cases","volume":"31","author":"Moersch","year":"1956","journal-title":"Proc. Staff Meet. Mayo Clin."},{"key":"10.1016\/j.jns.2019.06.021_bb0640","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.clineuro.2009.06.005","article-title":"Stiff person syndrome associated with lower motorneuron disease and infiltration of cytotoxic T cells in the spinal cord","volume":"111","author":"Holm\u00f8y","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2019.06.021_bb0645","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/mds.23784","article-title":"Pathological findings in a case of stiff person syndromewith anti-GAD antibodies","volume":"26","author":"Witherick","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.06.021_bb0650","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004010050956","article-title":"Large motor neuron involvement in Stiff-man syndrome:a qualitative and quantitative study","volume":"97","author":"Ishizawa","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2019.06.021_bb0655","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1054\/jocn.2001.1014","article-title":"Pathological evidence of encephalomyelitis in the stiffman syndrome with anti-GAD antibodies","volume":"9","author":"Warren","year":"2002","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2019.06.021_bb0660","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jns.2013.12.015","article-title":"Evidence of T-cell mediated neuronal injury in stiffpersonsyndrome with anti-amphiphysin antibodies","volume":"337","author":"Poh","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jns.2019.06.021_bb0665","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","article-title":"The clinical spectrum of anti-GAD antibody-positivepatients with stiff-person syndrome","volume":"55","author":"Dalakas","year":"2000","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.jns.2019.06.021_bb0670","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0002-9343(67)90057-5","article-title":"A critical survey of stiff-man syndrome","volume":"42","author":"Gordon","year":"1967","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb0675","first-page":"306","article-title":"Extralimbic autoimmuneencephalitis associated with glutamic acid decarboxylase antibodies: an underdiagnosed entity?","volume":"21","author":"Najjar","year":"2011","journal-title":"EpilepsyBehav"},{"issue":"4","key":"10.1016\/j.jns.2019.06.021_bb0680","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Anti-bodies to glutamic aciddecarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0705","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-2008-1041222","article-title":"Stiff-man syndrome","volume":"11","author":"McEvoyK","year":"1991","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0710","first-page":"90P","article-title":"Increased motor cortex excitability instiffperson syndrome: a paired pulse TMS study","volume":"107","author":"Sandbrink","year":"1998","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0715","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/eat.20794","article-title":"Stiff-personsyndrome presenting as eating disorder: a case report","volume":"44","author":"Cuturic","year":"2011","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.jns.2019.06.021_bb0720","article-title":"Why it is not always anxiety: A tough diagnosis of Stiff person Syndrome","volume":"2017","author":"Cervantes","year":"2017","journal-title":"Case Rep. Neurol. Med."},{"issue":"8","key":"10.1016\/j.jns.2019.06.021_bb0725","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic \u00a8 neurological syndromes andglutamic acid decarboxylase antibodies","volume":"72","author":"Arino","year":"2015","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0730","doi-asserted-by":"crossref","first-page":"215","DOI":"10.17712\/nsj.2016.3.20150596","article-title":"Anti-glutamic acid decarboxylase antibody positive neurological syndromes","volume":"21","author":"Tohid","year":"2016","journal-title":"Neurosciences"},{"issue":"9","key":"10.1016\/j.jns.2019.06.021_bb0735","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jamaneurol.2013.3499","article-title":"Neuronal surface and glutamic aciddecarboxylase autoantibodies in nonparaneoplastic stiff person syndrome","volume":"70","author":"Chang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0740","article-title":"Difficult to treatfocal, stiff person syndrome of the left upper extremity","author":"Esplin","year":"2017","journal-title":"Case Rep. Neurol. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb0745","first-page":"203","article-title":"A new and effective drug in the treatment of the stiff-man syndrome: preliminaryreport","volume":"38","author":"Howard","year":"1963","journal-title":"Proc. Staff Meet. Mayo Clin."},{"key":"10.1016\/j.jns.2019.06.021_bb0750","doi-asserted-by":"crossref","first-page":"18e23","DOI":"10.1016\/j.coph.2005.10.003","article-title":"GABA-based therapeutic approaches: GABAA receptor subtype functions","volume":"6","author":"Rudolph","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"18","key":"10.1016\/j.jns.2019.06.021_bb0760","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1977.03270450020010","article-title":"Stiff-man syndrome and clonazepam","volume":"237","author":"Westblom","year":"1977","journal-title":"JAMA."},{"issue":"Pt 12","key":"10.1016\/j.jns.2019.06.021_bb0765","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/brain\/awl245","article-title":"Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome","volume":"129","author":"Raju","year":"2006","journal-title":"Brain."},{"key":"10.1016\/j.jns.2019.06.021_bb0770","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/ner.12765","article-title":"Case series: intrathecal baclofen therapy in stiff-personsyndrome","volume":"21","author":"Abbatemarco","year":"2018","journal-title":"Neuromodulation"},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0775","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.1966.03100030116038","article-title":"Stiff-man syndrome. Two patients treated with diazepam","volume":"195","author":"Cohen","year":"1966","journal-title":"JAMA."},{"key":"10.1016\/j.jns.2019.06.021_bb0780","doi-asserted-by":"crossref","first-page":"115e7","DOI":"10.4103\/0028-3886.60420","article-title":"Intrathecal baclofen pump implantation in a case of stiff person syndrome","volume":"58","author":"Maramattom","year":"2010","journal-title":"Neurol. India"},{"issue":"10","key":"10.1016\/j.jns.2019.06.021_bb0785","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1212\/WNL.45.10.1893","article-title":"Intrathecalbaclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial","volume":"45","author":"Silbert","year":"1995","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.jns.2019.06.021_bb0790","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF00866910","article-title":"Stiff-person syndrome with anti-glutamic aciddecarboxylase autoantibodies: complete remission of symptoms after intrathecal baclofenadministration","volume":"242","author":"Seitz","year":"1995","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0795","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00415-009-5331-z","article-title":"Effects of immunotherapy on motor cortex excitability in Stiff PersonSyndrome","volume":"257","author":"Rossi","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0800","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00023210-200115070-00002","article-title":"Stiff man syndrome","volume":"15","author":"Meinck","year":"2001","journal-title":"CNS Drugs"},{"issue":"26","key":"10.1016\/j.jns.2019.06.021_bb0805","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulinfor stiff-person syndrome","volume":"345","author":"Dalakas","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2019.06.021_bb0810","doi-asserted-by":"crossref","first-page":"I19","DOI":"10.1007\/s00415-005-1105-4","article-title":"The role of IVIg in the treatment of patients with stiff person syndrome and otherneurological diseases associated with anti-GAD antibodies","volume":"252","author":"Dalakas","year":"2005","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0815","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mds.10043","article-title":"Effect of treatment with intravenous immunoglobulin on quality of lifein patients with stiff-person syndrome","volume":"17","author":"Gerschlager","year":"2002","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.jns.2019.06.021_bb0820","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4065\/74.12.1231","article-title":"Long-term remission of refractory stiff-man syndrome after treatment withintravenous immunoglobulin","volume":"74","author":"Khanlou","year":"1999","journal-title":"Mayo Clin. Proc."},{"issue":"11","key":"10.1016\/j.jns.2019.06.021_bb0825","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/01.WNL.0000074394.15882.83","article-title":"Strokes, thromboembolic events, and IVIg: rare incidents blemish anexcellent safety record","volume":"60","author":"Dalakas","year":"2003","journal-title":"Neurology."},{"issue":"23","key":"10.1016\/j.jns.2019.06.021_bb0830","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1212\/01.wnl.0000313840.27060.bf","article-title":"Invited article: inhibition of B cell functions: implications for neurology","volume":"70","author":"Dalakas","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.06.021_bb0835","first-page":"S21","article-title":"Double-blind, placebo-controlled study ofrituximab in patients with stiff-person syndrome (SPS)","volume":"66","author":"Dalakas","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0840","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010838","article-title":"Long-lived plasma cellsand memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff person Syndrome","volume":"5","author":"Rizzi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2019.06.021_bb0845","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ana.25002","article-title":"A double-blind,placebo-controlled study of rituximab in patients with stiff person syndrome","volume":"82","author":"Dalakas","year":"2017","journal-title":"Ann. Neurol."},{"issue":"8668","key":"10.1016\/j.jns.2019.06.021_bb0850","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(89)91568-7","article-title":"Plasma exchange andimmunosuppression in the stiff man syndrome","volume":"2","author":"Harding","year":"1989","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jns.2019.06.021_bb0855","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198906013202220","article-title":"Plasmapheresis in the treatment of stiff-man syndrome","volume":"320","author":"Vicari","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jns.2019.06.021_bb0860","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/trf.12573","article-title":"Efficacy of therapeutic plasma exchange fortreatment of stiff-person syndrome","volume":"54","author":"Pagano","year":"2014","journal-title":"Transfusion."},{"issue":"7","key":"10.1016\/j.jns.2019.06.021_bb0865","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/trf.12573","article-title":"Efficacy of therapeutic plasma exchange fortreatment of stiff-person syndrome","volume":"54","author":"Pagano","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.jns.2019.06.021_bb0870","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jca.21431","article-title":"Therapeutic plasma exchange in two patients with Stiff-person Syndrome","volume":"31","author":"Huy","year":"2016","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.jns.2019.06.021_bb0875","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1537-2995.1999.39399219285.x","article-title":"Frequency ofimmediate adverse effects associated with therapeutic apheresis","volume":"39","author":"McLeod","year":"1999","journal-title":"Transfusion."},{"issue":"10","key":"10.1016\/j.jns.2019.06.021_bb0880","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/head.12246","article-title":"The CARE guidelines: consensusbasedclinical case reporting guideline development","volume":"53","author":"Gagnier","year":"2013","journal-title":"Headache."},{"key":"10.1016\/j.jns.2019.06.021_bb0885","series-title":"Muscles: Testing and Functionwith Posture and Pain","author":"Kendall","year":"2005"},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0890","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/095939899307694","article-title":"Intra- and inter-rater reliability andfactorial validity studies of the physiotherapy functional mobility profile (PFMP) in acute care patients","volume":"15","author":"Brosseau","year":"1999","journal-title":"Physiother. Theory Pract."},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0895","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.25167","article-title":"Treatment of stiff-personsyndrome with chronic plasmapheresis","volume":"28","author":"De la Casa-Fages","year":"2013","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb0900","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.NPT.0000282147.18446.b8","article-title":"Physical therapy during in-patient rehabilitation for a patient with Stiff-personSyndrome","volume":"30","author":"Potter","year":"2006","journal-title":"J. Neurol. Phys. Ther."},{"key":"10.1016\/j.jns.2019.06.021_bb0905","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/practneurol-2011-000071","article-title":"Stiff person syndrome","volume":"11","author":"Hadavi","year":"2011","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0910","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000212375","article-title":"Stiff person syndrome","volume":"26","author":"Duddy","year":"2009","journal-title":"Neurol. Neurosci."},{"key":"10.1016\/j.jns.2019.06.021_bb0915","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.51.1.250","article-title":"Atypicalstiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression","volume":"51","author":"Schmierer","year":"1998","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.06.021_bb0920","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","article-title":"Stiff-person syndrome with amphiphysin antibodies, distinctivefeatures of a rare disease","volume":"71","author":"Murinson","year":"2008","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.jns.2019.06.021_bb0925","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1212\/NXI.0000000000000438","article-title":"Glycine receptor modulating antibody predicting treatable stiff-personspectrum disorders","volume":"5","author":"Hinson","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb0930","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00936885","article-title":"Stiff man syndrome: neurophysiological findingsin eight patients","volume":"242","author":"Meinck","year":"1995","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb0935","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1212\/NXI.0000000000000416","article-title":"Multiplex family with GAD65-Abs neurologic syndromes","volume":"5","author":"Belbezier","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2019.06.021_bb0940","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/jnnp.45.12.1159","article-title":"Jerking stiff-man syndrome","volume":"45","author":"Alberca","year":"1982","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb0945","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2019.06.021_bb0950","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology divyanshu","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb0955","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.seizure.2014.04.009","article-title":"Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications","author":"Lilleker","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.jns.2019.06.021_bb0960","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2019.06.021_bb0970","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jnnp.71.1.100","article-title":"Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases","volume":"71","author":"Meinck","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2019.06.021_bb0975","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0896-6273(00)81165-4","article-title":"Autoimmunity to gephyrin in Stiff-man syndrome","volume":"26","author":"Butler","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2019.06.021_bb0980","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1212\/NXI.0000000000000438","article-title":"Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders","volume":"5","author":"Shannon","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm. March"},{"key":"10.1016\/j.jns.2019.06.021_bb0990","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.06.021_bb0995","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jocn.2011.08.034","article-title":"Electrophysiological characteristics in four patients from Brazil with stiff person syndrome","volume":"19","author":"Lorenzoni","year":"2012","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2019.06.021_bb1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-018-1232-z","article-title":"Dalakas quantitative clinical and autoimmuneassessments in stiff person syndrome: evidence for a progressive disorder","volume":"19","author":"Rakocevic","year":"2019","journal-title":"BMC Neurol."},{"issue":"6","key":"10.1016\/j.jns.2019.06.021_bb1005","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1212\/01.wnl.0000237558.83349.d0","article-title":"Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies","volume":"67","author":"Rakocevic","year":"2006","journal-title":"Neurology."},{"issue":"9","key":"10.1016\/j.jns.2019.06.021_bb1010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2008.02246.x","article-title":"EFNS guidelines for the use of intravenous immunglobulin in treatment of neurological diseases. EFNS task force on the use of intra venous immunglobulin in treatment of neurological disease","volume":"15","author":"Elovaara","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1015","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00415-008-0007-7","article-title":"Levetiracetam in stiff-person syndrome","volume":"255","author":"Sechi","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1025","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for stiff-person syndrome","volume":"345","author":"Dalakas","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb1030","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/trf.12573","article-title":"Efficacy of therapeutic plasma exchange for treatment of stiff-person syndrome","volume":"54","author":"Pagano","year":"2014","journal-title":"Transfusion."},{"key":"10.1016\/j.jns.2019.06.021_bb1035","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.05.2010.3021","article-title":"Stiff-person syndrome treated with rituximab","author":"Lobo","year":"2010","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jns.2019.06.021_bb1040","first-page":"627","article-title":"Reducing excess stiffness in Stiff person Syndrome using CBT: a case study","volume":"35","author":"Morrisa","year":"2014","journal-title":"NeuroRehabilitation."},{"key":"10.1016\/j.jns.2019.06.021_bb1045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2710.2012.01365.x","article-title":"Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report","volume":"38","author":"Vicente-Valor","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jns.2019.06.021_bb1050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mus.23416","article-title":"Botulinum toxin A in anti-GAD-positive stiff-limb syndrome","volume":"46","author":"Anagnostou","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2019.06.021_bb1055","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/jnnp-2013-305425","article-title":"Successful treatment of stiff person syndrome with sequential use of tacrolimus","volume":"84","author":"Nakane","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb1060","first-page":"217","article-title":"Anesthesia considerations in stiff person syndrome","volume":"22","author":"Sidransky","year":"2013","journal-title":"Middle East J. Anaesthesiol."},{"key":"10.1016\/j.jns.2019.06.021_bb1070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000313871","article-title":"Spinal cord stimulation to abort painful spasms of atypical stiff limb syndrome","volume":"88","author":"Ughratdar","year":"2010","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.jns.2019.06.021_bb1075","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1212\/WNL.31.9.1162","article-title":"Improvement of stiff-man syndrome with sodium valproate","volume":"31","author":"Spehlmann","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb1080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.57.2.366","article-title":"Improvement of stiff-person syndrome with tiagabine","volume":"57","author":"Murinson","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb1085","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(05)64825-8","article-title":"Improvement of stiff-man syndrome with vigabatrin","volume":"348","author":"Vermeij","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2019.06.021_bb1090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11940-003-0024-x","article-title":"Stiff-person Syndrome","volume":"5","author":"Vasconcelos","year":"2003","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1095","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412","article-title":"Stiff-man syndrome treated with intrathecal baclofen","volume":"43","author":"Penn","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb1100","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJM198406073102306","article-title":"Resolution of stiff-man syndrome with cortisol replacement in a patient with deficiencies of ACTH, growth hormone, and prolactin","volume":"310","author":"George","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb1105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF02337009","article-title":"Steroid-responsive and dependent stiff-man syndrome: a clinical and electrophysiological study of two cases","volume":"9","author":"Piccolo","year":"1988","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.06.021_bb1110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.1966.03100030116038","article-title":"Stiff-man syndrome. Two patients treated with diazepam","volume":"195","author":"Cohen","year":"1966","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2019.06.021_bb1115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1553-2712.1995.tb03627.x","article-title":"Stiff-man syndrome: case report","volume":"2","author":"Kuhn","year":"1995","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.jns.2019.06.021_bb1120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp.47.3.280","article-title":"The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine","volume":"47","author":"Meinck","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.06.021_bb1125","first-page":"861","article-title":"The stiff-person syndrome. Case report","volume":"68","author":"Piovano","year":"2002","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.jns.2019.06.021_bb1130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp.47.3.280","article-title":"The stiff-man syndrome: newpathophysiological aspects from abnormal exteroceptive re-flexes and the response to clomipramine, clonidine, and tiza-nidine","volume":"47","author":"Meinck","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb1135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1215\/S1152851703000395","article-title":"Immunomodulatory treatment trial for paraneoplastic neurological disorders","volume":"6","author":"Vernino","year":"2004","journal-title":"Neuro-oncol."},{"key":"10.1016\/j.jns.2019.06.021_bb1140","series-title":"Motor Unit Hyperactivity States","first-page":"45","article-title":"Stiff-man syndrome: clinical aspects and anti\u2013islet cell antibodies as a disease marker","year":"1993"},{"issue":"18","key":"10.1016\/j.jns.2019.06.021_bb1145","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1212\/01.wnl.0000284606.00074.f1","article-title":"Unexpected benefit of propofol in stiff-person syndrome","volume":"70","author":"Hattan","year":"2008","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.jns.2019.06.021_bb1150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1155","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/S1353-8020(09)70799-0","article-title":"Stiff-person syndrome","volume":"15","author":"Gershanik","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"7","key":"10.1016\/j.jns.2019.06.021_bb1160","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.33.7.930","article-title":"On the mechanism of sudden death in Moersch-Woltman syndrome","volume":"33","author":"Goetz","year":"1983","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.06.021_bb1165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12028-016-0296-0","article-title":"Acute respiratory failure in a patient with stiff-person syndrome","volume":"25","author":"Jachiet","year":"2016","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.jns.2019.06.021_bb1170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNN.0b013e31804c701e","article-title":"A patient with post-traumatic stress disorder developing Stiff person Syndrome is there a correlation?","volume":"20","author":"Dinnerstein","year":"2007","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2377-13-76","article-title":"Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study","volume":"13","author":"Takagi","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-003-1673-x","article-title":"Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction","volume":"174","author":"Lewis","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2019.06.021_bb1185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2004.02.017","article-title":"GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum","volume":"72","author":"Fatemi","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jns.2019.06.021_bb1190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1113\/jphysiol.2004.078915","article-title":"Defined types of cortical interneurone structure space and spike timing in the hippocampus","volume":"562","author":"Somogyi","year":"2005","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb1195","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1212\/WNL.59.3.449","article-title":"Increased brainstem excitability in stiff person syndrome","volume":"59","author":"Molloy","year":"2002","journal-title":"Neurology."},{"issue":"7","key":"10.1016\/j.jns.2019.06.021_bb1200","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0025-6196(12)65157-X","article-title":"Clinical neurophysiologic studies in stiff-man syndrome: use of simultaneous video-electroencephalographic\u2013surface electromyographic recording","volume":"65","author":"Armon","year":"1990","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.jns.2019.06.021_bb1205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00312924","article-title":"Electrophysiological studies on the \u201cstiff-man\u201d syndrome","volume":"217","author":"Mamoli","year":"1977","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2019.06.021_bb1210","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1212\/WNL.44.10.1952","article-title":"The acoustic startle reflex in stiffman syndrome","volume":"44","author":"Matsumoto","year":"1994","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.06.021_bb1215","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0033-1334477","article-title":"Teene Stiff person Syndrome and other Anti-GAD\u2013associated neurologic disorders","volume":"32","author":"Dayalu","year":"2012","journal-title":"Semin. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2019.06.021_bb1225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-018-1232-z","article-title":"Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder","volume":"19","author":"Rakocevic","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1230","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb1235","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"Mckeon","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2019.06.021_bb1250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12883-018-1176-3","article-title":"A case report of rigidity and recurrent lower limb myoclonus: progressive encephalomyelitis rigidity and myoclonus syndrome, a chameleon. Degeneffe et al","volume":"18","author":"Aur\u00e9lie Degeneffe","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1265","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ana.410090516","article-title":"Baclofen in the treatment of stiff-man syndrome","volume":"9","author":"Miller","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1275","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1212\/WNL.45.10.1893","article-title":"Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial","volume":"45","author":"Silbert","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb1280","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1212\/WNL.49.6.1591","article-title":"Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus","volume":"49","author":"Stayer","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb1285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000313871","article-title":"Spinal cord stimulation to abort painful spasms of atypical stiff limb syndrome","volume":"88","author":"Ughratdar","year":"2010","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.jns.2019.06.021_bb1290","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.25167","article-title":"Treatment of stiff-person syndrome with chronic plasmapheresis","volume":"28","author":"De la Casa-Fages","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.06.021_bb1295","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/mds.870080323","article-title":"Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A","volume":"8","author":"Davis","year":"1993","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.jns.2019.06.021_bb1300","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","article-title":"The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome","volume":"55","author":"Dalakas","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2019.06.021_bb1305","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.transci.2019.03.015","article-title":"Role of plasma exchange in stiff person syndrome","volume":"58","author":"Albahra","year":"2019","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jns.2019.06.021_bb1320","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jocn.2009.06.015","article-title":"Rituximab treatment of stiff-person syndrome in a patient with thymoma, diabetes mellitus and autoimmune thyroiditis","volume":"17","author":"Dupond","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2019.06.021_bb1325","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00415-011-6123-9","article-title":"Stiff person syndrome (SPS) complicated by respiratory failure: successful treatment with rituximab","volume":"259","author":"Qureshi","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1330","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-010027","article-title":"Antiglycine receptor antibody and encephalomyelitis with rigidity and myoclonus (PERM) related to small cell lung cancer","author":"Kyskan","year":"2013","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jns.2019.06.021_bb1335","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.clineuro.2013.09.002","article-title":"Miller fisher syndrome with positivity of anti-GAD antibodies","volume":"115","author":"Pietrini","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2019.06.021_bb1340","first-page":"237","article-title":"Stiff person syndrome and motor mononeuropathy with conduction block: a singular association","volume":"157","author":"La Spada","year":"2006","journal-title":"Clin. Ter."},{"key":"10.1016\/j.jns.2019.06.021_bb1345","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1177\/0883073808315617","article-title":"Leucoencephalopathy, transverse myelopathy, and peripheral neuropathy in association with glutamic acid decarboxylase-65 (GAD) antibodies in children with cancer","volume":"23","author":"Ledet","year":"2008","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1360","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.04.010","article-title":"Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients","volume":"211","author":"Errichiello","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2019.06.021_bb1365","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.06.021_bb1370","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1468-1331.2011.03609.x","article-title":"Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies","volume":"19","author":"Falip","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1375","first-page":"13","article-title":"Epilepsy and autoimmunity in pediatric patients","volume":"46","author":"Bekta\u015f","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jns.2019.06.021_bb1380","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ane.12799","article-title":"Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies","volume":"137","author":"Falip","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.06.021_bb1385","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00415-015-8002-2","article-title":"Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings","volume":"263","author":"Baysal-Kirac","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2018.09.009","article-title":"The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients","volume":"63","author":"Elisak","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.jns.2019.06.021_bb1395","first-page":"57","article-title":"Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs. Front","volume":"9","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"Neurol."},{"issue":"8","key":"10.1016\/j.jns.2019.06.021_bb1400","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","article-title":"Cerebellar Ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy","volume":"71","author":"Ari\u00f1o","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.06.021_bb1405","first-page":"1","article-title":"Adolescent stiff person syndrome: long term symptom remission on immunomodulatory therapy","author":"Ogilvie","year":"2019","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.06.021_bb1410","first-page":"7","article-title":"Is Stiff person Syndrome benefited by physical therapy intervention? Summary of case reports","author":"Vaiyapuri","year":"2019","journal-title":"Biomed. Res. Int."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19302813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19302813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:48:37Z","timestamp":1758383317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19302813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":259,"alternative-id":["S0022510X19302813"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.06.021","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SPS: Understanding the complexity","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}